Capital Fund Management (CFM)
TAK icon

Capital Fund Management (CFM)’s Takeda Pharmaceutical TAK Stock Holding History

Capital Fund Management (CFM)’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-77,690
Closed -$1.14M – 2647
2025
Q3 		$1.14M Sell
77,690
-48,589
-38% -$722K ﹤0.01% 2049
2025
Q2 		$1.95M Buy
126,279
+86,333
+216% +$1.28M 0.01% 1696
2025
Q1 		$594K Buy
+39,946
New +$560K ﹤0.01% 1808
2024
Q2 		– Sell
-69,026
Closed -$959K – 2166
2024
Q1 		$959K Sell
69,026
-25,920
-27% -$377K ﹤0.01% 1726
2023
Q4 		$1.35M Buy
+94,946
New +$1.35M ﹤0.01% 1722
2022
Q3 		– Sell
-66,141
Closed -$929K – 1644
2022
Q2 		$929K Buy
66,141
+37,557
+131% +$536K 0.01% 1096
2022
Q1 		$409K Buy
28,584
+4,481
+19% +$65.8K ﹤0.01% 1343
2021
Q4 		$329K Buy
+24,103
New +$338K ﹤0.01% 1516
2020
Q1 		– Sell
-90,513
Closed -$1.79M – 2006
2019
Q4 		$1.79M Sell
90,513
-309
-0.3% -$5.91K 0.01% 882
2019
Q3 		$1.56M Sell
90,822
-2,755
-3% -$47.6K 0.01% 869
2019
Q2 		$1.66M Sell
93,577
-3,129
-3% -$56.9K 0.02% 853
2019
Q1 		$1.97M Buy
+96,706
New +$1.95M 0.02% 816

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Capital Fund Management (CFM)'s TAK Position: Q4 2025 in Review

Capital Fund Management (CFM) sold out of Takeda Pharmaceutical (TAK) in Q4 2025, closing a stake of 77,690 shares — an estimated $1.14M sold.

Capital Fund Management (CFM) first reported a position in TAK in Q1 2019 and held it in 12 quarters. The position peaked at $1.97M in Q1 2019. 349 funds tracked by Wall St. Rank hold TAK as of Q4 2025.

  • Capital Fund Management (CFM) reported no remaining Takeda Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 77,690 Takeda Pharmaceutical shares in Q4 2025, an estimated $1.14M.
  • Capital Fund Management (CFM) first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 12 quarters.
  • Capital Fund Management (CFM)'s Takeda Pharmaceutical position peaked at $1.97M in Q1 2019.
  • 349 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2025, filed 17 Feb 2026.